Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genomic Expression has commercialized its OneRNA® test, a CLIA‑validated RNA sequencing diagnostic used in breast and ovarian cancers to identify optimal treatment options. The company is developing methods to translate tumor RNA profiles into individualized RNA therapeutics, including mRNA vaccines. Early clinical results show high diagnostic yield and potential to improve patient outcomes by matching therapies based on tumor transcriptomics. No FDA approval required due to CLIA status; ready for broader commercial launch.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genomic Expression.